SOC is one of two non-essential outer capsid proteins in the large T4 bacteriophage. Structurally, it is a rod-shaped molecule that functions to "decorate" the outer surface of the mature icosahedral viral head. The utility of SOC extends beyond its structural role, providing a versatile multi-component display platform for the presentation of exogenous peptides and proteins. This capability offers unprecedented opportunities for elucidating the finer details of icosahedral viral architecture and, critically, for applications such as antibody development and vaccine discovery.
SOC belongs to a family of viral "triplex" proteins that adorn the exterior of large icosahedral viruses. This family includes proteins such as gpD in phage lambda, gpDec in phage L, pIX in adenovirus, and the vp19-(vp23)2 complex in human herpesviruses. While these triplex proteins share the common functional attribute of decorating the outer capsid, they exhibit no obvious sequence similarity and display extreme specificity for the mature conformational state of their respective vesicle proteins. For instance, P22 triplex proteins can discriminate subtle conformational differences in capsid proteins at the quasi-three-fold axes versus the true icosahedral three-fold vertices. These proteins, including SOC, are instrumental in viral assembly and, subsequently, for biotechnological applications such as the display of exogenous molecules, the study of protein-protein interactions, and the targeted delivery of antigens or genes.
Unlock the Potential of SOC Display. Request a Consultation Today.
The T4 SOC protein offers distinct advantages that elevate it above other triplex display systems, making it an ideal choice for high-impact applications:
Unlike other triplex proteins, SOC exists in extraordinarily high copy numbers, with 810 copies per capsid. This density is significantly higher than, for example, the 420 copies of gpD in lambda phage or the 240 copies of pIX in adenovirus. This high valency is crucial for increasing the local concentration of the displayed ligand, enhancing avidity effects, and improving the sensitivity of screening processes for low-affinity binders.
A key feature of SOC is that it is completely dispensable for phage viability and infectivity. Furthermore, SOC-binding sites only emerge after critical steps of capsid assembly, following maturation cleavage, prohead expansion, and DNA packaging within the capsid. This unique temporal regulation allows for the robust in vitro assembly of recombinant SOC or SOC fusion antigens onto SOC- phage or empty expanded capsids under defined, controlled conditions. This capability simplifies the purification and loading process, offering a powerful alternative to in vivo display methods that can be limited by E. coli expression capacity.
SOC binds with high affinity and exclusively to the surface of phage particles in vitro. The instability of SOC- phage at high pH (e.g., pH 10.6, where wild-type phages are stable) provides a means to quantify viral infectivity based on structural changes, confirming the intimate relationship between SOC binding and capsid integrity and stability.
Ready to Start Your Project? Speak With Our SOC Display Specialists.
Leveraging years of specialized experience in bacteriophage biology and display technology, Creative Biolabs has established a state-of-the-art platform to harness the power of T4 phage display using SOC. Our professional technical team and advanced scientific infrastructure are dedicated to providing comprehensive services that ensure the successful application of this high-density display system.
Our platform supports two primary, highly efficient approaches to achieve SOC-site presentation:
This method capitalizes on the post-assembly binding property of SOC. The SOC fusion protein is first efficiently expressed in E. coli, followed by isolation and purification. The purified fusion protein is then replicated and added to soc- phage particles or multimeric heads lacking the SOC protein, resulting in the high-density display of the desired cargo.
This traditional genetic approach allows for the stable integration of the foreign gene into the T4 phage genome, enabling in vivo display.
The integration of the in vitro HOC display platform positions Creative Biolabs at the forefront of designing the T4 phage outer capsid for complex library construction.
Accelerate Your Binder Discovery with SOC Display — Contact Us to Get Started.
Creative Biolabs offers a full suite of services built around the robust phage display system to accelerate binder discovery. Our expertise spans the entire workflow, from library design to lead candidate identification:
Designing and constructing high-quality phage libraries, including proprietary high-capacity display formats, tailored for diverse targets (e.g., antibodie and peptides).
Utilizing advanced biopanning and selection strategies to screen display libraries against various antigens, including complex membrane proteins and challenging targets.
Isolating high-affinity, specific monoclonal antibody candidates from synthetic or immunized libraries using the high-density SOC platform.
Identifying novel peptide ligands for therapeutic or diagnostic applications.
Focusing selection on binders exhibiting enhanced stability against thermal or chemical denaturation, a critical factor for downstream development.
Isolating binders that exhibit selective binding dependent on pH changes, which is highly desirable for targeted delivery systems that utilize the pH differential between the bloodstream and the acidic endosomal compartment.
Using phage display, we search specifically for antibodies that can actually make the cell pull them inside, allowing any linked payload to enter the target cell with them.
Our profound knowledge and extensive experience in antibody phage display assure our clients of optimal outcomes in their discovery programs.
Discover Whether SOC Display Fits Your Target Molecules — Ask Our Scientists for Guidance.
Consult Our Phage Display Experts
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.